Dementia

Published on 10/04/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1236 times

Dementia

Chorea Ataxia Wernicke–Korsakoff syndrome See above Supranuclear gaze palsy Neuropathy/spinal cord syndrome Vitamin B12 and folic acid deficiency Usually raised mean red blood cell volume Weakness and fasciculation Motor neurone disease (MND) dementia Evolves to MND with dementia (p. 108)

The role of the clinician is to identify less common treatable conditions, to advise regarding prognosis and to identify the rare familial diseases for which counselling may be important. The clinician forms part of a multidisciplinary team that coordinates care. Medical treatment may be helpful in the management of some associated problems, such as Parkinsonism, seen in some conditions, and complications such as behavioural abnormalities.

Examination

Bed-side neurological testing of higher function (pp. 12–13) seeking to measure the deficits is combined with a detailed neurological examination. The latter usually only finds non-specific features, such as frontal release signs (snout, grasp reflexes), but may find evidence of associations such as Parkinsonism or focal signs that may point to alternative disease (frontal lesions; see Table 1). Awareness of the mental state is important because depression is one of the most treatable differential diagnoses.

Investigations

These include formal psychometry for the documentation of cognitive deficits and as a baseline in patients with subtle defects to allow repetition to demonstrate progression. Other causes can be sought with brain imaging (CT or MRI) and a blood screen, including vitamin B12, thyroid function and syphilis serology (Box 1).

The aim of these assessments is to identify treatable causes and to attempt to characterize the pattern of dementia in neurodegenerative dementias. The latter aim is to identify AD, for which there are now some potential specific therapies.

Alzheimer’s disease

AD represents over 70% of cases of dementia. The prevalence increases from 300 per 100 000 at age 60–69 years to 20% over age 85 years.

Other dementias

Other dementias

Structural brain disease, for example frontal tumours or hydrocephalus, can produce a dementia. Normal pressure hydrocephalus (NPH) is a syndrome where there is a loss of higher function, a gait apraxia (p. 62) and urinary incontinence. This is associated with an enlargement of the lateral ventricles, but not the cerebral sulci, without obstruction. Some patients improve after shunting. Diagnosis is difficult.

Occasionally dementia can be caused by metabolic or nutritional disturbance, for example hypothyroidism, vitamin B12/folic acid or thiamine deficiency. Thiamine deficiency is common (up to 7% of dementia) and is seen in alcoholics, the malnourished and occasionally in hyperemesis of pregnancy. It causes a characteristic picture of memory disturbance (Korsakoff’s syndrome) with an inability to retain new information and variable retrograde amnesia associated with confabulation. In acute deficiency, there may be Wernicke’s encephalopathy with confusion and eye movement disorders, mixed with acute alcohol withdrawal.

Vascular disease, usually recurrent infarction (arteriosclerosis or rarely vasculitis) or occasionally recurrent haemorrhage (amyloid angiopathy, arteriovenous malformations) may cause a stepwise decline over months or years. There are usually other focal signs such as hemianopia. Cerebrovascular disease may coexist with Alzheimer’s disease.

Epilepsy may present with recurrent subtle seizures that mimic cognitive decline. Usually there is a history of more obvious seizures and of more clear-cut fluctuations in the patient’s condition, with episodes of confusion early in the illness.